Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price fell 7% during mid-day trading on Tuesday . The stock traded as low as $162.5750 and last traded at $162.5750. 95 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 640 shares. The stock had previously closed at $174.7740.
Merck KGaA Stock Down 7.0%
The firm has a 50-day moving average of $148.02 and a two-hundred day moving average of $144.17. The firm has a market cap of $21.01 billion, a price-to-earnings ratio of 24.82 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
- These 3 Dividend Stocks Could Boost Your Income This July
- Rocket Lab Defies Gravity With $8B Buyout
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
